Salivary Fusobacterium nucleatum serves as a potential diagnostic biomarker for gastric cancer

Table 1 Association of Fusobacterium nucleatum levels in saliva with clinicopathologic features

Feature	Number of cases	Fusobacterium nucleatum level	P value
Age (yr)			0.780
< 61	56	153.00 (39.20-542.00)
≥ 61	64	204.00 (57.30-566.00)
Gender			0.961
Male	99	161.00 (53.52-620.60)
Female	21	213.60 (46.63-335.90)
Tumor size (cm)			0.450
< 5	76	152.90 (52.21-443.80)
≥ 5	44	239.90 (47.31-846.80)
Pathological differentiation			0.658
Well	77	147.50 (33.98-543.90)
Moderate	33	155.80 (84.94-754.60)
Poor	10	280.80 (78.46-518.70)
Invasion depth			0.227
T1	29	124.60 (32.21-415.80)
T2	60	298.30 (76.58-666.90)
T3	21	102.10 (68.62-385.70)
T4	10	223.00 (66.99-790.30)
Lymph nodes metastasis			< 0.001
N0	43	80.14 (23.98-241.80)
N1	25	324.50 (72.43-549.10)
N2	22	239.60 (79.36-501.70)
N3	30	478.00 (96.09-1054.00)